Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.

Noehr-Jensen L, Damkier P, Bidstrup TB, Pedersen RS, Nielsen F, Brosen K.

Eur J Clin Pharmacol. 2006 Jun;62(6):437-45. Epub 2006 Apr 28.

PMID:
16770647
2.

The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.

Bidstrup TB, Damkier P, Olsen AK, Ekblom M, Karlsson A, Brøsen K.

Br J Clin Pharmacol. 2006 Jan;61(1):49-57.

3.

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.

Bidstrup TB, Stilling N, Damkier P, Scharling B, Thomsen MS, Brøsen K.

Eur J Clin Pharmacol. 2004 Apr;60(2):109-14. Epub 2004 Mar 19.

PMID:
15034704
4.

CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.

Bidstrup TB, Bjørnsdottir I, Sidelmann UG, Thomsen MS, Hansen KT.

Br J Clin Pharmacol. 2003 Sep;56(3):305-14.

Supplemental Content

Loading ...
Support Center